CRMD

CorMedix (CRMD)

CorMedix Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRMD

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/06	21 : 30	GlobeNewswire Inc.	CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath	NASDAQ:CRMD	CorMedix Inc
2024/05/23	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CRMD	CorMedix Inc
2024/05/14	05 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRMD	CorMedix Inc
2024/05/10	06 : 06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:CRMD	CorMedix Inc
2024/05/09	21 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CRMD	CorMedix Inc
2024/05/09	20 : 40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRMD	CorMedix Inc
2024/04/19	21 : 30	GlobeNewswire Inc.	CorMedix Inc. Announces CMS Grants TDAPA to DefenCath	NASDAQ:CRMD	CorMedix Inc
2024/04/15	21 : 30	GlobeNewswire Inc.	CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)	NASDAQ:CRMD	CorMedix Inc
2024/03/12	20 : 30	GlobeNewswire Inc.	CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:CRMD	CorMedix Inc
2024/01/31	07 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRMD	CorMedix Inc
2024/01/19	06 : 53	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:CRMD	CorMedix Inc
2024/01/18	10 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRMD	CorMedix Inc
2024/01/18	10 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRMD	CorMedix Inc
2024/01/18	10 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRMD	CorMedix Inc
2024/01/18	10 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRMD	CorMedix Inc
2023/12/15	22 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRMD	CorMedix Inc
2023/12/15	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRMD	CorMedix Inc
2023/12/15	06 : 05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CRMD	CorMedix Inc
2023/11/22	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRMD	CorMedix Inc
2023/11/17	06 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRMD	CorMedix Inc
2023/11/15	06 : 05	GlobeNewswire Inc.	CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update	NASDAQ:CRMD	CorMedix Inc
2023/10/31	05 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRMD	CorMedix Inc
2023/10/11	21 : 30	GlobeNewswire Inc.	CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference	NASDAQ:CRMD	CorMedix Inc
2023/09/14	06 : 26	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:CRMD	CorMedix Inc
2023/09/14	06 : 25	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CRMD	CorMedix Inc
2023/09/14	06 : 20	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CRMD	CorMedix Inc
2023/09/09	05 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRMD	CorMedix Inc
2023/09/08	21 : 30	GlobeNewswire Inc.	CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology	NASDAQ:CRMD	CorMedix Inc
2023/08/30	21 : 00	GlobeNewswire Inc.	CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath	NASDAQ:CRMD	CorMedix Inc
2023/08/17	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRMD	CorMedix Inc